SmallCell Lung Cancer Therapeutics Market - Global Industry Insights, Trends,Outlook, and Opportunity Analysis, 2018-2026
Small Cell Lung Cancer (SCLC) ismalignant form of cancer arising within the lungs. SCLC is characterized byhigh growth rate, shorter doubling time than the non-small cell lung tumors.SCLC is more responsive to chemotherapy than NSCLC. Small cell lung cancer ishighly associated with tobacco, unhealthy food, alcohol, HIV infected, chronicinfections or related family history, and physical inactivity. The decrease insmoking is reflected as the substantial decrease in the incidence of SCLC. Thesymptoms include dyspnea, blood in sputum, weight loss, cough, and debility.
Global rise in number of cancercases expected to support the growth of small cell lung cancer therapeuticsmarket in the near future
According to the American CancerSociety Statistics in 2016, maximum cases of SCLC occur in individuals aged60-80 years with an estimated global death rate being 30,000 per year. Also,according to the World Health Organization (WHO), lung cancer is the secondmost prevailing cancer in men and women causing 1.59 million deaths in 2012.The rising prevalence of lung cancer, rise in unhealthy lifestyle, the launchof innovative radiation therapies, and premium priced drugs are the majorfactors driving the growth of lung cancer therapeutics market.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/799
Additionally, rising demand fortargeted therapies and platinum-based chemotherapies is likely to have an optimisticimpact on the small lung cancer therapeutics market in the forecast period.Also, increasing diagnostic facilities by the government, provision ofguidelines to cancer patients by International Healthcare Organizations are themajor factors contributing to the rising of small cell lung cancer market.However, expensive treatments, lack of awareness leading to late diagnosis arethe major factors restraining the small cell lung cancer market growth.
Enhanced health care dynamics toboost the Asia Pacific small cell lung cancer market
Regional segmentation of smallcell lung cancer therapeutics market by Coherent Market Insights comprises ofNorth America, Europe, Asia Pacific, Latin America, the Middle East and Africa.According to the American Cancer Society Statistics in 2017, around 222,500cases of lung cancer were diagnosed with 116,990 prevailing in men and 105,510in women, where small cell lung cancer accounts for 15 percent of lung cancersin the U.S. North America is expected to dominate the market owing to the highdeveloped regions, improved healthcare setup, and growing awareness abouthealthcare. Asia Pacific is expected to drive the growth of SCLC market in theforecast period owing to the growing awareness of health care, governmentfunding, and the presence of medical requirements for cancer therapeutics inthe emerging economies such as India and China.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/small-cell-lung-cancer-therapeutics-market-799
Key players in the Small Cell LungCancer Therapeutics Market
Key players operating the smallcell lung cancer therapeutics market include Bristol-Myers Squibb,GlaxoSmithKline, Menarini, Sanofi, and ZIOPHARM Oncology.
Platinum derivatives segmentaccounts for highest revenue share owing to the higher metastasis control rate
The global small cell lung cancertherapeutics market is segmented on the basis of drug therapy, and distributionchannel.
On the basis of drug therapy, theglobal small cell lung cancer therapeutics market is segmented into:
Targeted Therapy Drugs
Immunotherapy Drugs
Platinum Derivatives
On the basis of distributionchannel, the global small cell lung cancer therapeutics market is segmentedinto:
Hospital Pharmacies
Retail and Online Pharmacies
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/799
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
